摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2R,3S)-2-[3,4-bis[[tert-butyl(dimethyl)silyl]oxy]phenyl]-5,7-bis[[tert-butyl(dimethyl)silyl]oxy]-3,4-dihydro-2H-chromen-3-amine | 853687-48-6

中文名称
——
中文别名
——
英文名称
(2R,3S)-2-[3,4-bis[[tert-butyl(dimethyl)silyl]oxy]phenyl]-5,7-bis[[tert-butyl(dimethyl)silyl]oxy]-3,4-dihydro-2H-chromen-3-amine
英文别名
——
(2R,3S)-2-[3,4-bis[[tert-butyl(dimethyl)silyl]oxy]phenyl]-5,7-bis[[tert-butyl(dimethyl)silyl]oxy]-3,4-dihydro-2H-chromen-3-amine化学式
CAS
853687-48-6
化学式
C39H71NO5Si4
mdl
——
分子量
746.338
InChiKey
OETLLPSFYSUVRY-LWQYYNMXSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    12.23
  • 重原子数:
    49
  • 可旋转键数:
    13
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.69
  • 拓扑面积:
    72.2
  • 氢给体数:
    1
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (2R,3S)-2-[3,4-bis[[tert-butyl(dimethyl)silyl]oxy]phenyl]-5,7-bis[[tert-butyl(dimethyl)silyl]oxy]-3,4-dihydro-2H-chromen-3-amine吡啶4-二甲氨基吡啶氢氟酸N,N'-二环己基碳二亚胺 作用下, 以 四氢呋喃二氯甲烷 为溶剂, 反应 18.0h, 生成 N-[(2R,3S)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,4-dihydro-2H-chromen-3-yl]-3,4,5-trihydroxybenzamide
    参考文献:
    名称:
    Synthesis and antibacterial activity of hydrolytically stable (−)-epicatechin gallate analogues for the modulation of β-lactam resistance in Staphylococcus aureus
    摘要:
    Hydrolytically more stable analogues of (-)-epicatechin gallate (ECg) have been synthesised from ECg where an amine or amide function has been substituted for the ester linkage that joins the C-ring with the galloyl D-ring. Sub-inhibitory concentrations (25 mg/L) of the amide analogue 7, possessing the natural C-3 stereochemistry, were able to reduce the resistance to oxacillin of three strains of methicillin resistant Staphylococcus aureus (BB 568, EMRSA-15 and EMRSA-16) comparable to levels achieved with ECg. (c) 2005 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2005.03.063
  • 作为产物:
    描述:
    (-)-ECG-7TBS 在 palladium on activated charcoal lithium aluminium tetrahydride 、 邻苯二甲酸二甲酯氢气 、 sodium cyanoborohydride 、 溶剂黄146 作用下, 以 四氢呋喃乙醇二氯甲烷 为溶剂, 反应 39.5h, 生成 (2R,3S)-2-[3,4-bis[[tert-butyl(dimethyl)silyl]oxy]phenyl]-5,7-bis[[tert-butyl(dimethyl)silyl]oxy]-3,4-dihydro-2H-chromen-3-amine
    参考文献:
    名称:
    Synthesis and antibacterial activity of hydrolytically stable (−)-epicatechin gallate analogues for the modulation of β-lactam resistance in Staphylococcus aureus
    摘要:
    Hydrolytically more stable analogues of (-)-epicatechin gallate (ECg) have been synthesised from ECg where an amine or amide function has been substituted for the ester linkage that joins the C-ring with the galloyl D-ring. Sub-inhibitory concentrations (25 mg/L) of the amide analogue 7, possessing the natural C-3 stereochemistry, were able to reduce the resistance to oxacillin of three strains of methicillin resistant Staphylococcus aureus (BB 568, EMRSA-15 and EMRSA-16) comparable to levels achieved with ECg. (c) 2005 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2005.03.063
点击查看最新优质反应信息

文献信息

  • [EN] PYRANS FOR USE IN THE TREATMENT OF INFECTION<br/>[FR] PYRANES DESTINES A ETRE UTILISES DANS LE TRAITEMENT DE L'INFECTION
    申请人:UNIV LONDON PHARMACY
    公开号:WO2006003458A1
    公开(公告)日:2006-01-12
    There is provided a novel compound of the general formula (I), in which each R is hydrogen, aryl, C1-6 alkyl, trialkylsilyl, or acyl, each R1 is selected from hydroxy, C1-6 alkoxy and acyloxy; each R2 is H, C1-4 alkyl, trialkylsilyl or acyl; R3 is H or Me; and n is 0 to 5 any of the alkyl groups including alkyl groups in alkoxy, acyl and acyloxy groups which may be substituted by aryl, C1-4 alkyl, C1-4 alkoxy, hydroxyl, trialkylsiloxy or acyloxy groups. The compound is an analogue of epigalcatechin galate or epicatechin galate, with an amide bonding placed of the natural ester bond, with resistance to hydrolysis by esterase enzymes. The compounds may be used to modulate the resistance to β-lactam antibiotics of various infections, especially methicillin resistant staphylococcus aureus (MRSA). Pharmaceutical compositions containing the novel compounds and combinations of the novel compounds and β-lactam antibiotics are described.
    提供一种新化合物,其通式为(I),其中每个R为氢,芳基,C1-6烷基,三烷基硅基或酰基,每个R1从羟基,C1-6烷氧基和酰氧基中选择;每个R2为H,C1-4烷基,三烷基硅基或酰基;R3为H或Me;n为0至5之间的任何烷基基团,包括可能被芳基,C1-4烷基,C1-4烷氧基,羟基,三烷基硅氧基或酰氧基取代的烷基基团。该化合物是表现为表儿茶素没食子酸或表儿茶素没食子酸的类似物,具有天然酯键的酰胺键位,对酯酶酶的水解具有抗性。这些化合物可用于调节各种感染对β-内酰胺类抗生素的耐药性,特别是耐甲氧西林金黄色葡萄球菌(MRSA)。描述了含有这种新化合物的药物组合和这些新化合物与β-内酰胺类抗生素的组合。
  • Synthesis and antibacterial activity of hydrolytically stable (−)-epicatechin gallate analogues for the modulation of β-lactam resistance in Staphylococcus aureus
    作者:James C. Anderson、Catherine Headley、Paul D. Stapleton、Peter W. Taylor
    DOI:10.1016/j.bmcl.2005.03.063
    日期:2005.5
    Hydrolytically more stable analogues of (-)-epicatechin gallate (ECg) have been synthesised from ECg where an amine or amide function has been substituted for the ester linkage that joins the C-ring with the galloyl D-ring. Sub-inhibitory concentrations (25 mg/L) of the amide analogue 7, possessing the natural C-3 stereochemistry, were able to reduce the resistance to oxacillin of three strains of methicillin resistant Staphylococcus aureus (BB 568, EMRSA-15 and EMRSA-16) comparable to levels achieved with ECg. (c) 2005 Elsevier Ltd. All rights reserved.
查看更多